Intuitive Surgical (NASDAQ:ISRG) EVP Mark Brosius Sells 46 Shares of Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG – Get Free Report) EVP Mark Brosius sold 46 shares of the business’s stock in a transaction dated Wednesday, November 18th. The shares were sold at an average price of $430.63, for a total transaction of $19,808.98. Following the transaction, the executive vice president directly owned 319 shares in the company, valued at approximately $137,370.97. The trade was a 12.60% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

  • On Monday, November 16th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The shares were sold at an average price of $444.38, for a total transaction of $20,441.48.
  • On Wednesday, October 28th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $441.60, for a total transaction of $26,937.60.
  • On Monday, October 26th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $451.75, for a total transaction of $27,556.75.
  • On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The stock was sold at an average price of $365.79, for a total transaction of $9,144.75.
  • On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $350.20, for a total transaction of $8,054.60.
  • On Tuesday, September 8th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The shares were sold at an average price of $361.23, for a total transaction of $16,616.58.
  • On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $375.57, for a total transaction of $28,918.89.

Intuitive Surgical Stock Performance

Shares of NASDAQ ISRG traded down $9.58 during midday trading on Wednesday, reaching $420.95. 2,213,548 shares of the stock were exchanged, compared to its average volume of 2,435,968. The stock has a market capitalization of $145.92 billion, a P/E ratio of 50.90, a PEG ratio of 3.02 and a beta of 1.45. The company has a 50 day simple moving average of $421.98 and a 200 day simple moving average of $428.75. Intuitive Surgical, Inc. has a twelve month low of $328.57 and a twelve month high of $603.88.

Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. The firm had revenue of $3.05 billion for the quarter, compared to analysts’ expectations of $2.91 billion. Intuitive Surgical had a return on equity of 18.17% and a net margin of 25.54%. The firm’s quarterly revenue was up 21.7% on a year-over-year basis. During the same period in the prior year, the firm posted $2.40 earnings per share. On average, research analysts expect that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Institutional Investors Weigh In On Intuitive Surgical

A number of institutional investors have recently modified their holdings of ISRG. Bank of America Corp DE increased its position in shares of Intuitive Surgical by 3.3% during the first quarter. Bank of America Corp DE now owns 3,616,973 shares of the medical equipment provider’s stock worth $1,667,388,000 after acquiring an additional 116,292 shares during the period. Bank of New York Mellon Corp acquired a new stake in shares of Intuitive Surgical in the second quarter valued at $1,335,753,000. Amundi boosted its holdings in Intuitive Surgical by 8.6% in the first quarter. Amundi now owns 2,428,356 shares of the medical equipment provider’s stock valued at $1,119,448,000 after purchasing an additional 193,096 shares during the period. Arrowstreet Capital Limited Partnership boosted its holdings in Intuitive Surgical by 95.3% in the first quarter. Arrowstreet Capital Limited Partnership now owns 2,105,544 shares of the medical equipment provider’s stock valued at $970,635,000 after purchasing an additional 1,027,475 shares during the period. Finally, Sumitomo Mitsui Trust Group Inc. grew its stake in Intuitive Surgical by 10.8% during the 3rd quarter. Sumitomo Mitsui Trust Group Inc. now owns 1,893,485 shares of the medical equipment provider’s stock worth $769,948,000 after purchasing an additional 184,044 shares in the last quarter. 83.64% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. TD Cowen reaffirmed a “buy” rating and issued a $485.00 price target on shares of Intuitive Surgical in a research note on Monday, October 19th. Wells Fargo & Company reiterated an “overweight” rating and set a $486.00 price target (down from $487.00) on shares of Intuitive Surgical in a report on Wednesday, October 21st. Erste Group Bank raised Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Wednesday, October 21st. Royal Bank Of Canada reduced their price objective on shares of Intuitive Surgical from $575.00 to $550.00 and set an “outperform” rating on the stock in a report on Wednesday, October 21st. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Intuitive Surgical in a research report on Thursday, November 12th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical currently has an average rating of “Moderate Buy” and an average target price of $495.90.

View Our Latest Stock Report on ISRG

Recent Intuitive Surgical Headlines

These are some of the ISRG headlines that stood out recently:

  • Positive Sentiment: A recent earnings-focused report highlighted 25% adjusted EPS growth to $3, supported by broader robotic-platform adoption and AI-related innovation. Revenue growth has also been strong. ISRG EPS climbs 25%
  • Neutral Sentiment: Another analysis argues ISRG may be near fair value despite revenue growth, focusing on whether future cash flows justify its valuation as competition increases and new robotic platforms enter the market. This valuation debate could limit enthusiasm for the shares. ISRG stock may be near fair value
  • Negative Sentiment: The earnings commentary also noted rising research and development costs and a litigation settlement, potential headwinds to profitability even as adjusted EPS increased. Zacks earnings analysis

About Intuitive Surgical

(Get Free Report)

Intuitive Surgical develops, manufactures and markets robotic-assisted systems for minimally invasive procedures. Its products include da Vinci surgical systems, which allow surgeons to control instruments and a high-definition vision system from a console, as well as the Ion endoluminal system, designed to assist with minimally invasive lung biopsies. The company also provides instruments, accessories, training and support services for its systems. Its technology is used in a range of surgical specialties, including urology, general surgery and gynecology.

Further Reading

Insider Buying and Selling by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.